Margaret Tooth - 20 May 2025 Form 4 Insider Report for TRUPANION, INC. (TRUP)

Signature
/s/ Christina Poler as attorney-in-fact for Margaret Tooth
Issuer symbol
TRUP
Transactions as of
20 May 2025
Net transactions value
-$147,714
Form type
4
Filing time
22 May 2025, 21:53:45 UTC
Previous filing
23 Apr 2025
Next filing
27 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tooth Margaret CEO, Director C/O TRUPANION, INC., 6100 4TH AVENUE SOUTH, SUITE 200, SEATTLE /s/ Christina Poler as attorney-in-fact for Margaret Tooth 22 May 2025 0001657025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRUP Common Stock Options Exercise $35,720 +4,000 +3.4% $8.93 122,784 20 May 2025 Direct F1
transaction TRUP Common Stock Sale $183,434 -4,000 -3.3% $45.86 118,784 20 May 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRUP Stock Option (right to buy) Options Exercise $0 -4,000 -12% $0.000000 28,000 20 May 2025 Common Stock 4,000 $8.93 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 29, 2024, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.6750 to $46.1100 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
F3 This stock option grant is fully vested.